Retail Crowd

Complete British News World

UK vaccination rates may slow down

It has become necessary to retest 1.7 million vaccines, as well as delayed vaccine shipments from India, which could slow the vaccination schedule in the coming weeks in the United Kingdom, Sky News.

British Health Secretary Matt Hancock reported the sad news to the House of Commons.

Such events are to be expected during such a complex process

– The minister said, adding that the delay in 1.7 million vaccine doses also proves that the strict safety standards are working.

Receipt of the vaccine manufactured by the Indian Serum Institute will also be delayed

Hancock added.

Matt Hancock
Photo: PRU / AFP

The head of the ministry drew attention to the fact that 12 million people should receive the second dose of the vaccine in April, and since this dose should be given within 12 weeks after the first dose, there is no possibility to delay this.

According to the minister, the United Kingdom is currently in the middle of the so-called plateau stage,

And since many of the second doses will have to be given to the population in April, this will lead to fewer people receiving the first vaccination. According to current plans, vaccinations can only be given to those under the age of 50 in exceptional cases, as priority is given to the elderly.

According to Pfizer, their shipments to the UK in the first three months of the year were at the planned pace.

According to AstraZeneca, there is no disruption to the domestic supply chain in the country, and no threat to the delivery schedule.

READ  Training Fate: Serhiy Reerprof already has a new squad - official

A spokesman for the Serum Institute said

A few weeks ago, five million doses were shipped to the UK and they will try to increase the volume later.

However, they must also make it available for the Indian Government Immunization Program.

European Commission President warns of the crisis of the century

Ursula von der Leyen, based on the latest European data, drew attention to the fact that the epidemiological situation in the European Union could become more dangerous than it is now.